Enforcement Report - Week of December 21, 2022
21 Dec 2022 //
FDA
Company led drug alert – Iohexol solution for injection (350mg/ml & 300 mgI/ml)
06 Feb 2020 //
GOVUK
Ligand Presents +ve Results from Phase 1 Trial of Captisol-enabled Iohexol
08 Nov 2019 //
BUSINESSWIRE
Ligand Completes Enrollment of Ph1 Clinical Trial of Captisol-enabled Iohexol
02 May 2019 //
BUSINESSWIRE
Enforcement Report - Week of December 26, 2018
26 Dec 2018 //
FDA
JCB Laboratories Receives Form 483
26 Nov 2018 //
FDA